Erratum to "Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer" [Radiother. Oncol. 78 (2006) 270-275] (DOI:10.1016/j.radonc.2006.02.017);Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer

Radiotherapy and Oncology

Volumn 78, Issue 3, 2006, Pages 270-275

  Saarilahti, Kauko ^a   Kouri, Mauri ^a   Collan, Juhani ^a   Kangasmäki, Aki ^a   Atula, Timo ^b   Joensuu, Heikki ^a   Tenhunen, Mikko ^a  

^a Department of Oncology ^*  (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Head and neck cancer; Intensity modulated radiotherapy; Radiotherapy; Submandibular gland; Xerostomia

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; PAROTID GLAND; PATIENT MONITORING; PATIENT SAFETY; PRIORITY JOURNAL; RADIATION RESPONSE; SALIVATION; SUBMANDIBULAR GLAND; TREATMENT OUTCOME; TREATMENT PLANNING; XEROSTOMIA;

EID: 33646491060     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.06.009     Document Type: Erratum

References (29)

1. ICRU. International comission on radiation units and measurements report 50: prescribing, recording and reporting photon beam therapy. Washington, DC, ICRU; 1993.
2. LENT SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys 1995;31: 1049-91.
3. Braam P.M., Roesink J.M., Moerland M.A., et al. Long-term parotid gland function after radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 659-664
4. Bussels B., Maes A., Flamen P., et al. Dose-response relationships within the parotid gland after radiotherapy for head and neck cancer. Radiother Oncol 73 (2004) 297-306
5. Bussels B., Maes A., Hermans R., et al. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer. Radiother Oncol 72 (2004) 119-127
6. Chao K.S., Ozyigit G., Tran B.N., et al. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 55 (2003) 312-321
7. Chao K.S., Wippold F.J., Ozyigit G., Tran B.N., and Dempsey J.F. Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 53 (2002) 1174-1184
8. Coppes R.P., Vissink A., and Konings A.W. Comparison of radiosensitivity of rat parotid and submandibular glands after different radiation schedules. Radiother Oncol 63 (2002) 321-328
9. Coppes R.P., Vissink A., Zeilstra L.J., and Konings A.W. Muscarinic receptor stimulation increases tolerance of rat salivary gland function to radiation damage. Int J Radiat Biol 72 (1997) 615-625
10. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
11. Dawson L.A., Anzai Y., Marsh L., et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 46 (2000) 1117-1126
12. Eisbruch A., Kim H.M., Terrell J.E., et al. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 50 (2001) 695-704
13. Eisbruch A., Rhodus N., Rosenthal D., et al. How should we measure and report radiotherapy-induced xerostomia?. Semin Radiat Oncol 13 (2003) 226-234
14. Jellema A.P., Doornaert P., Slotman B.J., Rene Leemans C., and Langendijk J.A. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?. Radiother Oncol 77 (2005) 164-171
15. Eisbruch A., Ten Haken R.K., Kim H.M., Marsh L.H., and Ship J.A. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 45 (1999) 577-587
16. Feng M., Jabbari S., Lin A., et al. Predictive factors of local-regional recurrences following parotid sparing intensity modulated or 3D conformal radiotherapy for head and neck cancer. Radiother Oncol 77 (2005) 32-38
17. Gregoire V., Coche E., Cosnard G., Hamoir M., and Reychler H. Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience. Radiother Oncol 56 (2000) 135-150
18. Jen Y.M., Shih R., Lin Y.S., et al. Parotid gland-sparing 3-dimensional conformal radiotherapy results in less severe dry mouth in nasopharyngeal cancer patients: a dosimetric and clinical comparison with conventional radiotherapy. Radiother Oncol 75 (2005) 204-209
19. Jha N., Seikaly H., Harris J., et al. Prevention of radiation induced xerostomia by surgical transfer of submandibular salivary gland into the submental space. Radiother Oncol 66 (2003) 283-289
20. Pathak K.A., Bhalavat R.L., Mistry R.C., et al. Upfront submandibular salivary gland transfer in pharyngeal cancers. Oral Oncol 40 (2004) 960-963
21. Pavy J.J., Denekamp J., Letschert J., et al. EORTC late effects working group. Late effects toxicity scoring: the SOMA scale. Int J Radiat Oncol Biol Phys 31 (1995) 1043-1047
22. Peter B., Van Waarde M.A., Vissink A., s-Gravenmade E.J., and Konings A.W. The role of secretory granules in radiation-induced dysfunction of rat salivary glands. Radiat Res 141 (1995) 176-182
23. Pigott K., Dische S., and Saunders M.I. Where exactly does failure occur after radiation in head and neck cancer?. Radiother Oncol 37 (1995) 17-19
24. Roesink J.M., Moerland M.A., Battermann J.J., Hordijk G.J., and Terhaard C.H. Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region. Int J Radiat Oncol Biol Phys 51 (2001) 938-946
25. Saarilahti K., Kouri M., Collan J., et al. Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function. Radiother Oncol 74 (2005) 251-258
26. Sobin L.H., and Fleming I.D. TNM classification of malignant tumors, fifth edition union internationale contre le cancer and the American joint committee on cancer. Cancer 80 (1997) 1803-1804
27. Spiegel J.H., Brys A.K., Bhakti A., and Singer M.I. Metastasis to the submandibular gland in head and neck carcinomas. Head Neck 26 (2004) 1064-1068
28. Van Esch A., Bohsung J., Sorvari P., et al. Acceptance tests and quality control (QC) procedures for the clinical implementation of intensity modulated radiotherapy (IMRT) using inverse planning and the sliding window technique: experience from five radiotherapy departments. Radiother Oncol 65 (2002) 53-70
29. Vissink A., s-Gravenmade E.J., Ligeon E.E., and Konings W.T. A functional and chemical study of radiation effects on rat parotid and submandibular/sublingual glands. Radiat Res 124 (1990) 259-265